These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18066014)

  • 41. DNA patenting: the end of an era?
    Hopkins MM; Mahdi S; Patel P; Thomas SM
    Nat Biotechnol; 2007 Feb; 25(2):185-7. PubMed ID: 17287750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biotech slumps in Q1.
    Lawrence S
    Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
    [No Abstract]   [Full Text] [Related]  

  • 43. 2005: biotech partners up.
    Lawrence S
    Nat Biotechnol; 2006 Feb; 24(2):126. PubMed ID: 16465145
    [No Abstract]   [Full Text] [Related]  

  • 44. Patenting the parts.
    Nat Biotechnol; 2007 Aug; 25(8):822. PubMed ID: 17687343
    [No Abstract]   [Full Text] [Related]  

  • 45. The patent gamble: strategic insights for playing the worldwide patent game.
    Barrett WA
    Nat Biotechnol; 2003 Dec; 21(12):1515-7. PubMed ID: 14647335
    [No Abstract]   [Full Text] [Related]  

  • 46. Recent patent applications in imaging technology.
    Nat Biotechnol; 2005 Oct; 23(10):1230. PubMed ID: 16211060
    [No Abstract]   [Full Text] [Related]  

  • 47. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 48. Global biotech expansion taking cues from Bayh-Dole.
    Howard K
    Nat Biotechnol; 2004 Jul; 22(7):919-20. PubMed ID: 15259190
    [No Abstract]   [Full Text] [Related]  

  • 49. Hedge funds gain edge by doubling biotech investments.
    Ransom J
    Nat Biotechnol; 2006 Apr; 24(4):373-4. PubMed ID: 16601707
    [No Abstract]   [Full Text] [Related]  

  • 50. Recent patent applications in angiogenesis research.
    Nat Biotechnol; 2006 Feb; 24(2):155. PubMed ID: 16465155
    [No Abstract]   [Full Text] [Related]  

  • 51. [Biotechnology research and generation of patents of interest to the health system].
    Plaza Gómez L; Albert Martínez A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Open source and biotech.
    Bains W
    Nat Biotechnol; 2005 Sep; 23(9):1046. PubMed ID: 16151387
    [No Abstract]   [Full Text] [Related]  

  • 53. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 54. We speak for small biotech.
    Sherwin SA
    Nat Biotechnol; 2008 Jan; 26(1):27. PubMed ID: 18183009
    [No Abstract]   [Full Text] [Related]  

  • 55. We speak for small biotech.
    Vanhemelrijck J
    Nat Biotechnol; 2008 Jan; 26(1):27-8. PubMed ID: 18183008
    [No Abstract]   [Full Text] [Related]  

  • 56. VC funding hits high in Q1.
    Lawrence S
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract]   [Full Text] [Related]  

  • 57. Biotech as Bush bows out.
    Lorenzo A
    Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
    [No Abstract]   [Full Text] [Related]  

  • 58. Biotech knowledge trust.
    Wilan KH
    Nat Biotechnol; 2005 Aug; 23(8):921-3. PubMed ID: 16114122
    [No Abstract]   [Full Text] [Related]  

  • 59. The rise of the European bioentrepreneur.
    Alper J
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE3-5. PubMed ID: 12089569
    [No Abstract]   [Full Text] [Related]  

  • 60. Who speaks for small biotech?
    Nat Biotechnol; 2007 Jul; 25(7):693. PubMed ID: 17621276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.